Page last updated: 2024-10-29

avapro and Bradyarrhythmia

avapro has been researched along with Bradyarrhythmia in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Left ventricular hypertrophy has been associated with the prolongation of QT-time, and an increased risk of ventricular arrhythmias."1.32Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog. ( Leunissen, JD; Londoño, C; Ramakers, C; Schoenmakers, M; van Opstal, JM; Vos, MA, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schoenmakers, M1
Ramakers, C1
van Opstal, JM1
Leunissen, JD1
Londoño, C1
Vos, MA1
Bonvini, RF1
Hendiri, T1
Anwar, A1

Other Studies

2 other studies available for avapro and Bradyarrhythmia

ArticleYear
Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog.
    Cardiovascular research, 2003, Aug-01, Volume: 59, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Bradycardia; Chymases;

2003
Sinus arrest and moderate hyperkalemia.
    Annales de cardiologie et d'angeiologie, 2006, Volume: 55, Issue:3

    Topics: Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Biphenyl Compounds; Bradycardia; Depression, C

2006